Clinical Research Directory
Browse clinical research sites, groups, and studies.
Percutaneous Thermal Ablation in Lung Tumors
Sponsor: Assiut University
Summary
Lung cancer has a high incidence globally, with Egypt having it as the third most common and most lethal cancer, affecting 16.9% of males and 3.8% of females. While surgery is the preferred treatment for stage 1 non-small cell lung cancer due to positive outcomes, it carries significant risks due to patient comorbidities. Non-invasive treatments like radio frequency ablation (RFA) and microwave ablation (MWA) are alternatives for those unable to undergo surgery. These techniques use energy to destroy tumor tissue with minimal invasiveness and can be guided by computed tomography to ensure accurate ablation.
Official title: Percutaneous Thermal Ablation in Treatment of Lung Cancer
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-05-01
Completion Date
2026-05-01
Last Updated
2025-03-24
Healthy Volunteers
No
Conditions
Interventions
Percutaneous thermal ablation of lung tumors
Percutaneous radiofrequency ablation
Locations (1)
Faculty of medicine
Asyut, Egypt